CD8A and metabolic dysfunction-associated steatohepatitis: During NASH in mice, the number of CD8+ T cells in the liver was increased, and lipid-conditioned CXCR6+ CD8+ T cells induce hepatocyte killing in a perforin-independent, FasL (CD95L)-dependent manner (61).